Becton, Dickinson and Company vs Merck & Company, Inc. — Stock Comparison
Becton, Dickinson and Company (BDX) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. narrowly edges Becton, Dickinson and Company on Q·Score (6.4 vs 5.8 out of 10), led by Growth (6.4 vs 4.7) and Sentiment (7.4 vs 5.8). Becton, Dickinson and Company scores higher on Quality, reflecting stronger profitability and returns. Analyst price targets imply similar upside for both: +5.2% for BDX and +6.4% for MRK.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 31% year-over-year.
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BDX vs MRK: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.4/10 versus Becton, Dickinson and Company (BDX) at 5.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BDX or MRK?
Merck & Company, Inc. (MRK) scores higher on Growth (6.4/10 vs 4.7/10). Becton, Dickinson and Company reports revenue growth (5.4% YoY) while Merck & Company, Inc. reports (5.1% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BDX or MRK more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (7/10 vs 6.4/10). BDX trades at 14.0× P/E versus MRK at 15.1×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BDX vs MRK?
There are 12 analysts covering BDX with a consensus price target of $195.67, and 26 analysts covering MRK with a consensus target of $152.96. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BDX or MRK?
Becton, Dickinson and Company (BDX) scores higher on Quality (5.6/10 vs 4.9/10). Net profit margin: BDX at 4.2%, MRK at 4.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BDX or MRK?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.4/10). Market beta: BDX at 0.28, MRK at 0.23. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BDX and MRK?
Becton, Dickinson and Company (BDX) has a market capitalisation of $50.6B, while Merck & Company, Inc. (MRK) has a market cap of $354.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do BDX or MRK pay dividends?
BDX pays a dividend yield of 2.30%, while MRK pays a dividend yield of 2.35%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →